Actual Medicinal Product (AMP) - Balversa 4mg tablets (Janssen-Cilag Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Balversa 4mg tablets | Start Date 04-12-2024 | End Date |
Summary
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
| Code | Start Date | End Date |
|---|---|---|
| 44116811000001107 | 04-12-2024 |
Parent Products
-
VTMErdafitinib
-
VMPErdafitinib 4mg tablets
-
AMP(Current) Balversa 4mg tablets (Janssen-...
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 28 tablet | 1275000 | |
| 56 tablet | 1275000 |